Clinical Focus — Hair Loss

Mesotherapy for Hair Loss —
The 2026 Evidence

Hair loss affects one in three women and two in three men by age 50. Mesotherapy is now one of the most evidence-backed minimally invasive interventions available — but protocol matters enormously. Here is what the current science tells us.

Visit somuk.co.uk →

SoMUK · Founded 2013 · 22 Harley Street, London · Accredited Training · somuk.co.uk

“Summer is the season when patients notice hair thinning most — the contrast of sunlight, the comparison to others, the anxiety before a holiday. It is also when demand for hair restoration consultations peaks. Every practitioner seeing aesthetic patients should understand what mesotherapy can and cannot do for hair loss — and when to refer.” — Dr Philippe Hamida-Pisal, Medical Advisor, SoMUK

Why mesotherapy for hair?

Why mesotherapy is particularly suited to scalp treatment

The scalp presents a unique biological challenge for hair restoration: it is a highly vascularised area with a dense network of hair follicles, sebaceous glands, and supporting structures — but it is also covered by a relatively impermeable surface that limits topical delivery. This is precisely why injectable mesotherapy outperforms topical treatments for many patients: it bypasses the surface entirely and delivers actives directly to the follicular microenvironment where they are needed.

The hair follicle cycle — anagen (growth), catagen (transition), telogen (rest) — is regulated by a complex interplay of growth factors, hormones, and nutritional signals. Mesotherapy works by creating a favourable environment for follicle function: improving microcirculation, delivering essential nutrients, reducing DHT activity, and stimulating growth factor production at the follicular level.

Key principle

“Mesotherapy for hair loss is not a single treatment — it is a platform for delivering whatever the follicle environment is deficient in. The cocktail must be matched to the aetiology. The same protocol used for androgenetic alopecia will not work for telogen effluvium.”

Causes and indications

Which types of hair loss respond to mesotherapy?

Not all hair loss is the same — and mesotherapy is not appropriate for all types. Patient selection and accurate diagnosis are the foundation of successful outcomes.

Androgenetic Alopecia

The most common indication. DHT-sensitive follicles miniaturise over time. Mesotherapy with finasteride, dutasteride, minoxidil or DHT blockers delivered intradermally shows significant evidence of slowing progression and stimulating regrowth in early-to-mid stage loss. Responds well.

Telogen Effluvium

Triggered by stress, nutritional deficiency, hormonal change, post-illness, or post-partum. Follicles are intact but resting. Nutrient-rich cocktails (biotin, zinc, vitamins B and C, amino acids) directly into the mesoderm support return to anagen phase. Excellent response.

Alopecia Areata

Autoimmune-driven patchy loss. Mesotherapy can support regrowth in stable, non-extensive cases but is not a standalone treatment. Combine with dermatological management. Refer extensive or rapidly progressing cases. Partial response.

Post-chemotherapy Hair Loss

Follicles are often intact but severely stressed. Nutrient and growth factor delivery via mesotherapy supports follicular recovery once chemotherapy is complete. Timing is critical — begin only after oncology clearance. Good supportive response.

Scarring Alopecia

Follicles are permanently destroyed in the scarred area. Mesotherapy cannot restore follicles where scarring is complete. Useful only at the periphery to preserve remaining follicles. Refer to dermatology. Not indicated in scarred areas.

Diffuse Female Hair Loss

Often multifactorial — hormonal, nutritional, stress. Comprehensive blood screening first (ferritin, thyroid, B12, vitamin D, androgens). Mesotherapy combined with systemic treatment typically needed. Good response with correct diagnosis.

What goes in the cocktail

Evidence-based mesotherapy cocktail ingredients for hair loss

The active ingredients used in hair mesotherapy cocktails are chosen based on the specific aetiology and the biological mechanisms involved. The following ingredients have the strongest current evidence base:

Ingredient	Mechanism in hair follicle
Minoxidil (intradermal)	Potassium channel opener — prolongs anagen phase, increases follicle size, improves dermal papilla vascularity. Highly effective for androgenetic alopecia at lower concentrations than topical due to direct delivery.
Dutasteride / Finasteride	5-alpha reductase inhibitor — reduces DHT conversion at follicle level. Intradermal delivery reduces systemic side effects vs. oral. Strong evidence for androgenetic alopecia.
Biotin (Vitamin B7)	Essential cofactor for keratin biosynthesis. Deficiency directly causes hair loss. Intradermal delivery bypasses variable oral absorption.
Zinc	5-alpha reductase inhibitor + essential for DNA synthesis in rapidly dividing follicle cells. Deficiency strongly linked to hair loss.
Vitamin C (ascorbic acid)	Antioxidant + collagen synthesis cofactor. Supports dermal papilla structure and follicular microenvironment. Also reduces scalp inflammation.
Amino acids (lysine, cysteine)	Building blocks of keratin — the primary structural protein of hair. Cysteine forms the disulfide bonds that give hair its strength and structure.
VEGF (Vascular Endothelial Growth Factor)	Promotes angiogenesis around the follicle — increased blood supply means improved nutrient delivery. Key mechanism in androgenetic alopecia response to mesotherapy.
Polynucleotides (PDRN)	Stimulates tissue repair, fibroblast proliferation, and growth factor production. Emerging strong evidence for hair restoration when combined with classic cocktails.

The clinical protocol

Recommended treatment protocol — 2026

Parameter	Recommendation
Initial assessment	Full blood screen (ferritin, thyroid panel, B12, vitamin D, androgens, full blood count) before any treatment. Trichoscopy assessment of follicle density and miniaturisation. Photograph baseline.
Session frequency	Every 2–4 weeks for initial 4–6 sessions, then monthly maintenance. More frequent sessions (weekly) in first month for telogen effluvium.
Injection technique	Nappage technique — multiple superficial injections across the scalp at 1–2cm intervals. Depth: 2–4mm into the dermis, above the follicle level. Avoid too deep (risks damaging follicles).
Volume per session	0.02–0.05ml per injection point. Total volume 2–5ml per session depending on area treated.
Needles	30–32G, 4mm needle. Mesotherapy gun can improve speed and consistency in experienced hands.
Results timeline	Reduced shedding: 4–6 weeks. Visible regrowth: 3–4 months. Full assessment at 6 months.
Maintenance	Every 2–3 months after initial course to sustain results. Without maintenance, benefit diminishes over 6–12 months.
Combination	Most effective combined with: PRP, low-level laser therapy (LLLT), and topical/oral medical management where indicated.

2025–2026 Evidence

A 2025 meta-analysis of 18 clinical studies found that intradermal mesotherapy significantly improved hair density and follicle count in androgenetic alopecia compared to topical minoxidil alone. Studies combining PDRN with classic mesotherapy cocktails showed the strongest results — with mean hair density improvements of 28–42% after 6 sessions. Patient satisfaction rates exceeded 80% across studies where correct patient selection and diagnosis were confirmed before treatment.

Patient FAQs

What patients ask most

Will mesotherapy regrow hair I have already lost?

It depends on how long the follicles have been dormant. In early-to-mid stage androgenetic alopecia where follicles are miniaturised but present, regrowth is achievable. In areas of long-standing baldness where follicles have been absent for many years, regrowth is unlikely. Trichoscopy assessment tells us which follicles are still viable before treatment begins.

Is it painful on the scalp?

The scalp has many nerve endings and some patients find it uncomfortable. A topical anaesthetic cream applied 30 minutes before treatment significantly reduces discomfort. Most patients describe the sensation as tolerable — similar to a mild pins-and-needles feeling across the scalp during treatment.

How does it compare to PRP?

PRP (platelet-rich plasma) delivers growth factors derived from the patient’s own blood. Mesotherapy delivers a customised cocktail of targeted actives. They work through complementary mechanisms — many practitioners use both in alternating sessions for optimal results. Neither is definitively superior; the combination typically outperforms either alone.

Can women have the same treatment as men?

The underlying actives are similar but the cocktail formulation is adjusted. For women, DHT-blocking agents require careful consideration, particularly for women of childbearing age. The investigation before treatment also differs — hormonal and nutritional screening is especially important in female patients.

Upcoming Training

2026 Masterclass Dates

22 Harley Street, London · Max 4 delegates · £600 per delegate · CPD accredited

Date	Course	Spaces	Book
Sat 6 Jun	Aesthetic Aesthetic Mesotherapy	4 left	BOOK
Sun 7 Jun	Pain Pain Management	4 left	BOOK
Mon 8 Jun	Aesthetic Skin Boosters Mesotherapy & Skin Boosters	4 left	BOOK
Sat 20 Jun	Aesthetic Exosomes Aesthetic Mesotherapy & Exosomes	4 left	BOOK
Sat 4 Jul	Aesthetic Aesthetic Mesotherapy	4 left	BOOK
Sun 5 Jul	Exosomes Skin Boosters Exosomes & Skin Boosters	4 left	BOOK

View all 22 dates at somuk.co.uk/training-calendar/

Society of Mesotherapy UK

Train in mesotherapy for hair loss at SoMUK

Accredited aesthetic mesotherapy training at 22 Harley Street, London. Hair restoration protocols covered in all aesthetic courses.

View Training Dates → Become a Member

contact@somuk.co.uk · +44 20 7580 9095 · 22 Harley Street, London W1G 9PL

Mesotherapy for Hair Loss — The 2026 Evidence